CD44 and neoplasm: Initially, we used flow cytometry to show that the immune checkpoint receptor Programmed Death Receptor 1 (PD-1) was expressed on activated (CD44+) CD8 T-cells in all tumor types (Figure 2—figure supplement 1B).